Author:
Tong Allison, ,Manns Braden,Hemmelgarn Brenda,Wheeler David C.,Tugwell Peter,Winkelmayer Wolfgang C.,van Biesen Wim,Crowe Sally,Kerr Peter G.,Polkinghorne Kevan R.,Howard Kirsten,Pollock Carol,Hawley Carmel M.,Johnson David W.,McDonald Stephen P.,Gallagher Martin P.,Urquhart-Secord Rachel,Craig Jonathan C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference65 articles.
1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med. 2004;351:1296–305.
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Am J Kidney Dis. 2007;72:247–59.
3. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518–31.
4. Australian Institute of Health and Welfare. Projections of the prevalence of treated end-stage kidney disease in Australia 2012–2020. Canberra, Australia: Australian Institute of Health and Welfare; 2014.
5. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333:1047.